| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/27/1997 | WO1997010887A1 Novel affinity ligands and their use |
| 03/27/1997 | WO1997010853A2 N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes |
| 03/27/1997 | WO1997010852A2 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes |
| 03/27/1997 | WO1997010850A1 Transcytosis vehicles and enhancers for drug delivery |
| 03/27/1997 | WO1997010844A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/27/1997 | WO1997010843A1 Modified p53 constructs and uses therefor |
| 03/27/1997 | WO1997010841A1 Antiangiogenic properties of endothelial-monocyte activating polypeptide ii |
| 03/27/1997 | WO1997010839A1 Compositions and methods for inhibiting the binding of pecam |
| 03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 03/27/1997 | WO1997010836A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras |
| 03/27/1997 | WO1997010831A1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 03/27/1997 | WO1997010828A1 Therapy for tissue membrane insufficiency |
| 03/27/1997 | WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 03/27/1997 | WO1997010711A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | WO1997005258A3 Recombinant 60kda vegetable panallergen (co-factor-independent phosphoglycerate mutase; e.c. 5.4.2.1.) |
| 03/27/1997 | WO1997002051A3 Cascade polymer complexes |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | DE19536785A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ S¶2¶NY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent S¶2¶NY for radioactive isotopes |
| 03/27/1997 | DE19536783A1 Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope Bifunctional nicotinamide-type chelating agent N¶2¶S¶2¶ for radioactive isotopes |
| 03/27/1997 | DE19536781A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNS für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent XSNS for radioactive isotopes |
| 03/27/1997 | DE19536780A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent XSNY for radioactive isotopes |
| 03/27/1997 | DE19535701A1 New (opt. protected) phosphorylated insulin cpds. |
| 03/27/1997 | DE19535445A1 Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine A process for producing natriuretic peptides via streptavidin-fusion proteins |
| 03/27/1997 | DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2232841A1 Process for producing natriuretic peptides via streptavidine fusion proteins |
| 03/27/1997 | CA2232750A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras |
| 03/27/1997 | CA2232733A1 Yeast receptor and g-protein fusion protein |
| 03/27/1997 | CA2232730A1 New adhesin from helicobacter pylori |
| 03/27/1997 | CA2232622A1 Method of adsorbing viruses from fluid compositions |
| 03/27/1997 | CA2232515A1 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | CA2232391A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as xsns for radioactive isotypes |
| 03/27/1997 | CA2232340A1 Bifunctional nicotinamide-chelating agents such as n2s2 for radioactive isotopes |
| 03/27/1997 | CA2232299A1 Uses of bone morphogenetic proteins |
| 03/27/1997 | CA2232193A1 Dna encoding medicinal proteins |
| 03/27/1997 | CA2231806A1 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 03/27/1997 | CA2231394A1 High level expression of proteins |
| 03/27/1997 | CA2230479A1 Transcytosis vehicles and enhancers for drug delivery |
| 03/27/1997 | CA2230138A1 Cyclin/cdk proteins, and uses related thereto |
| 03/27/1997 | CA2230119A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | CA2229845A1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 03/27/1997 | CA2227306A1 Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection |
| 03/27/1997 | CA2222035A1 Streptavidin mutants |
| 03/26/1997 | EP0764724A1 Nucleic acid treatment and plasmids comprising at least a phage resistance mechanism, bacterias containing them and their utilisation |
| 03/26/1997 | EP0764723A1 Nucleic acid sequences and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their utilisation |
| 03/26/1997 | EP0764722A2 DNA encoding primate leptins as medicinal proteins |
| 03/26/1997 | EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same |
| 03/26/1997 | EP0764657A1 Diagnostic and therapeutic compositions and methods for lipoprotein(a) |
| 03/26/1997 | EP0764445A2 Acellular vaccine |
| 03/26/1997 | EP0764273A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 03/26/1997 | EP0764213A1 Recombinant aav genome encoding immunodeficiency virus protein |
| 03/26/1997 | EP0764212A1 Use of anthocyanin genes to maintain male sterile plants |
| 03/26/1997 | EP0764210A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 03/26/1997 | EP0764209A1 Yeast strains |
| 03/26/1997 | EP0764208A1 Bmp-9 compositions |
| 03/26/1997 | EP0764203A1 Methods for selectively stimulating proliferation of t cells |
| 03/26/1997 | EP0764202A1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
| 03/26/1997 | EP0764172A1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764170A1 Branched synthetic peptide conjugate |
| 03/26/1997 | EP0763982A1 Novel bioemulsifiers |
| 03/26/1997 | EP0698096B1 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 03/26/1997 | EP0642531B1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method |
| 03/26/1997 | EP0585217B1 Preparation exhibiting enzymatic delignification activity, a method of producing the same, and applications thereof |
| 03/26/1997 | EP0546087B1 Protein structure of the plant toxin gelonin |
| 03/26/1997 | EP0482080B1 Small cyclic platelet aggregation inhibitors |
| 03/26/1997 | CN1146216A Novel gene originating in corynebacterium and use thereof |
| 03/26/1997 | CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146155A Method for implanting encapsulated cells in a host |
| 03/26/1997 | CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells |
| 03/26/1997 | CN1145953A DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses |
| 03/26/1997 | CN1145952A Gene encoding endoglycoceramidase activator |
| 03/26/1997 | CN1145808A Human growth horomne agent for adults |
| 03/26/1997 | CN1034335C Extraction and purification of an anticoagulant principle from the south american leech haementeria ghilanii |
| 03/25/1997 | US5614620 DNA binding proteins including androgen receptor |
| 03/25/1997 | US5614619 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
| 03/25/1997 | US5614618 Origin of replication complex genes |
| 03/25/1997 | US5614612 Genetic engineering, vaccines, hiv |
| 03/25/1997 | US5614609 Serine threonine kinase receptor |
| 03/25/1997 | US5614587 Collagen-based bioadhesive compositions |
| 03/25/1997 | US5614507 Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia |
| 03/25/1997 | US5614500 Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
| 03/25/1997 | US5614499 Anticoagulants; treatment or prophylaxis of thrombosis |
| 03/25/1997 | US5614497 Treatment of hypertension, cardiovascular disease and renal disease |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614494 Peptides for heparin and low molecular weight heparin anticoagulation reversal |
| 03/25/1997 | US5614492 Diabetes |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614419 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 03/25/1997 | US5614413 Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
| 03/25/1997 | US5614409 Production of IBDV VP2 in highly immunogenic form |
| 03/25/1997 | US5614406 Kainate-binding human CNS receptors of the EAA2 family |
| 03/25/1997 | US5614404 Plasmid vector for insertion of human immunodeficiency virus dna sequences into a pox virus |
| 03/25/1997 | US5614403 In vitro replication system capable of rescuing cloned and manipulated rotavirus genes |
| 03/25/1997 | US5614402 5' nucleases derived from thermostable DNA polymerase |
| 03/25/1997 | US5614399 Plant ubiquitin promoter system |
| 03/25/1997 | US5614397 Method and compositions for modulating lifespan of hematolymphoid cells |